Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group

Effective systemic therapies suppress toxic light chain production leading to an increased proportion of patients with light chain (AL) amyloidosis who survive longer albeit with end-stage renal disease. There is a critical need to identify patients in this population who benefit from renal transpla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Havasi, Andrea (VerfasserIn) , Heybeli, Cihan (VerfasserIn) , Leung, Nelson (VerfasserIn) , Angel-Korman, Avital (VerfasserIn) , Sanchorawala, Vaishali (VerfasserIn) , Cohen, Oliver (VerfasserIn) , Wechalekar, Ashutosh (VerfasserIn) , Bridoux, Frank (VerfasserIn) , Jaffer, Insara (VerfasserIn) , Gutgarts, Victoria (VerfasserIn) , Hassoun, Hani (VerfasserIn) , Levinson, Maya (VerfasserIn) , Rosenbaum, Cara (VerfasserIn) , Milani, Paolo (VerfasserIn) , Palladini, Giovanni (VerfasserIn) , Merlini, Giampaolo (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Schönland, Stefan (VerfasserIn) , Veelken, Kaya (VerfasserIn) , Pogrebinsky, Alexander (VerfasserIn) , Doros, Gheorghe (VerfasserIn) , Landau, Heather (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 August 2022
In: Blood cancer journal
Year: 2022, Jahrgang: 12, Heft: 8, Pages: 1-8
ISSN:2044-5385
DOI:10.1038/s41408-022-00714-5
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41408-022-00714-5
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41408-022-00714-5
Volltext
Verfasserangaben:Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros and Heather Landau

MARC

LEADER 00000caa a2200000 c 4500
001 181694727X
003 DE-627
005 20230427035137.0
007 cr uuu---uuuuu
008 220919s2022 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41408-022-00714-5  |2 doi 
035 |a (DE-627)181694727X 
035 |a (DE-599)KXP181694727X 
035 |a (OCoLC)1361696435 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Havasi, Andrea  |e VerfasserIn  |0 (DE-588)1268397202  |0 (DE-627)1816947075  |4 aut 
245 1 0 |a Outcomes of renal transplantation in patients with AL amyloidosis  |b an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group  |c Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros and Heather Landau 
264 1 |c 18 August 2022 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.09.2022 
520 |a Effective systemic therapies suppress toxic light chain production leading to an increased proportion of patients with light chain (AL) amyloidosis who survive longer albeit with end-stage renal disease. There is a critical need to identify patients in this population who benefit from renal transplantation. This multicenter, observational study from five countries includes 237 patients with AL amyloidosis who underwent renal transplantation between 1987 and 2020. With a median follow-up of 8.5 years, the median overall survival from renal transplantation was 8.6 years and was significantly longer in patients with complete and very good partial hematologic responses (CR + VGPR) compared to less than VGPR (9 versus 6.8 years; HR: 1.5, P = 0.04 [95% CI: 1-2.1]) at renal transplantation. Median graft survival was 7.8 years and was better in the CR + VGPR group (8.3 vs 5.7 years, HR: 1.4, P = 0.05 [95% CI: 1-2]). The frequency and time to amyloid recurrence in the graft was also lower (16% vs 37%, p = 0.01) and longer (median time not achieved vs 10 years, p = 0.001) in the CR + VGPR group. Comparing CR vs. VGPR there was no difference in overall or graft survival. Although 69 patients (29%) experienced hematologic relapse, treatment effectively prevented graft loss in the majority (87%). Renal transplantation in selected AL amyloidosis patients is associated with extended overall and renal graft survival. Patients with hematologic CR or VGPR have the most favorable outcomes, and these patients should be considered for renal transplantation. 
650 4 |a Haematological cancer 
650 4 |a Medical research 
700 1 |a Heybeli, Cihan  |e VerfasserIn  |4 aut 
700 1 |a Leung, Nelson  |e VerfasserIn  |4 aut 
700 1 |a Angel-Korman, Avital  |e VerfasserIn  |4 aut 
700 1 |a Sanchorawala, Vaishali  |e VerfasserIn  |4 aut 
700 1 |a Cohen, Oliver  |e VerfasserIn  |4 aut 
700 1 |a Wechalekar, Ashutosh  |e VerfasserIn  |4 aut 
700 1 |a Bridoux, Frank  |e VerfasserIn  |4 aut 
700 1 |a Jaffer, Insara  |e VerfasserIn  |4 aut 
700 1 |a Gutgarts, Victoria  |e VerfasserIn  |4 aut 
700 1 |a Hassoun, Hani  |e VerfasserIn  |4 aut 
700 1 |a Levinson, Maya  |e VerfasserIn  |4 aut 
700 1 |a Rosenbaum, Cara  |e VerfasserIn  |4 aut 
700 1 |a Milani, Paolo  |e VerfasserIn  |4 aut 
700 1 |a Palladini, Giovanni  |e VerfasserIn  |4 aut 
700 1 |a Merlini, Giampaolo  |e VerfasserIn  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
700 1 |a Veelken, Kaya  |d 1988-  |e VerfasserIn  |0 (DE-588)1155327845  |0 (DE-627)1016744269  |0 (DE-576)501617655  |4 aut 
700 1 |a Pogrebinsky, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Doros, Gheorghe  |e VerfasserIn  |4 aut 
700 1 |a Landau, Heather  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood cancer journal  |d [London] : Springer Nature, 2011  |g 12(2022), 8, Artikel-ID 119, Seite 1-8  |h Online-Ressource  |w (DE-627)655134174  |w (DE-600)2600560-8  |w (DE-576)339571802  |x 2044-5385  |7 nnas  |a Outcomes of renal transplantation in patients with AL amyloidosis an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group 
773 1 8 |g volume:12  |g year:2022  |g number:8  |g elocationid:119  |g pages:1-8  |g extent:8  |a Outcomes of renal transplantation in patients with AL amyloidosis an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group 
856 4 0 |u https://doi.org/10.1038/s41408-022-00714-5  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41408-022-00714-5  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220919 
993 |a Article 
994 |a 2022 
998 |g 1155327845  |a Veelken, Kaya  |m 1155327845:Veelken, Kaya  |d 910000  |d 910100  |e 910000PV1155327845  |e 910100PV1155327845  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |d 50000  |e 910000PS122405226  |e 910100PS122405226  |e 50000PS122405226  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 18 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |d 50000  |e 910000PH1028373708  |e 910100PH1028373708  |e 50000PH1028373708  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 17 
999 |a KXP-PPN181694727X  |e 4189992100 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Havasi, Andrea","family":"Havasi","role":"aut","given":"Andrea"},{"family":"Heybeli","display":"Heybeli, Cihan","role":"aut","given":"Cihan"},{"display":"Leung, Nelson","family":"Leung","given":"Nelson","role":"aut"},{"given":"Avital","role":"aut","display":"Angel-Korman, Avital","family":"Angel-Korman"},{"role":"aut","given":"Vaishali","family":"Sanchorawala","display":"Sanchorawala, Vaishali"},{"family":"Cohen","display":"Cohen, Oliver","given":"Oliver","role":"aut"},{"role":"aut","given":"Ashutosh","family":"Wechalekar","display":"Wechalekar, Ashutosh"},{"display":"Bridoux, Frank","family":"Bridoux","given":"Frank","role":"aut"},{"role":"aut","given":"Insara","family":"Jaffer","display":"Jaffer, Insara"},{"role":"aut","given":"Victoria","family":"Gutgarts","display":"Gutgarts, Victoria"},{"display":"Hassoun, Hani","family":"Hassoun","role":"aut","given":"Hani"},{"role":"aut","given":"Maya","display":"Levinson, Maya","family":"Levinson"},{"role":"aut","given":"Cara","display":"Rosenbaum, Cara","family":"Rosenbaum"},{"display":"Milani, Paolo","family":"Milani","role":"aut","given":"Paolo"},{"family":"Palladini","display":"Palladini, Giovanni","role":"aut","given":"Giovanni"},{"display":"Merlini, Giampaolo","family":"Merlini","given":"Giampaolo","role":"aut"},{"role":"aut","given":"Ute","family":"Hegenbart","display":"Hegenbart, Ute"},{"display":"Schönland, Stefan","family":"Schönland","role":"aut","given":"Stefan"},{"given":"Kaya","role":"aut","display":"Veelken, Kaya","family":"Veelken"},{"given":"Alexander","role":"aut","family":"Pogrebinsky","display":"Pogrebinsky, Alexander"},{"display":"Doros, Gheorghe","family":"Doros","role":"aut","given":"Gheorghe"},{"role":"aut","given":"Heather","display":"Landau, Heather","family":"Landau"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Outcomes of renal transplantation in patients with AL amyloidosis","title_sort":"Outcomes of renal transplantation in patients with AL amyloidosis","subtitle":"an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group"}],"note":["Gesehen am 16.09.2022"],"origin":[{"dateIssuedDisp":"18 August 2022","dateIssuedKey":"2022"}],"id":{"eki":["181694727X"],"doi":["10.1038/s41408-022-00714-5"]},"recId":"181694727X","relHost":[{"part":{"volume":"12","extent":"8","pages":"1-8","year":"2022","text":"12(2022), 8, Artikel-ID 119, Seite 1-8","issue":"8"},"language":["eng"],"id":{"zdb":["2600560-8"],"issn":["2044-5385"],"eki":["655134174"]},"recId":"655134174","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Outcomes of renal transplantation in patients with AL amyloidosis an international collaboration through The International Kidney and Monoclonal Gammopathy Research GroupBlood cancer journal","pubHistory":["1.2011-"],"note":["Gesehen am 17.07.24"],"origin":[{"publisher":"Springer Nature ; Nature Publ. Group","dateIssuedKey":"2017","dateIssuedDisp":"2017-","publisherPlace":"[London] ; London [u.a.]"}],"title":[{"title":"Blood cancer journal","title_sort":"Blood cancer journal"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros and Heather Landau"]}} 
SRT |a HAVASIANDROUTCOMESOF1820